Tanezumab Reduces Osteoarthritis Knee Pain, Phase II Study Finds

Just months after a pharmaceutical company halted studies of tanezumab, a drug used in reducing pain and improving function in people with moderate-to-severe osteoarthritis of the knee, the results of a small, phase II clinical trial found only a few minor side effects and substantial improvement in patient conditions Read more

Speak Your Mind


The material provided on this web site is for educational purposes only, and is not under any circumstances to be used for medical advice, diagnosis or treatment. See additional information here. Use of this site is subject to our Terms of Use and Privacy Policy. | Sitemap | Contact Us